<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03289351</url>
  </required_header>
  <id_info>
    <org_study_id>17-011</org_study_id>
    <nct_id>NCT03289351</nct_id>
  </id_info>
  <brief_title>Randomized Control Trial: Two Different Antibiotics Versus One Antibiotic for Pediatric Perforated Appendicitis</brief_title>
  <official_title>Randomized Control Trial: Two Different Antibiotics Versus One Antibiotic for Pediatric Perforated Appendicitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phoenix Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phoenix Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      After appendix has been removed for perforated appendicitis, patients will receive
      postoperative antibiotics. In the last 5 years, the literature has transitioned from a 3
      -drug therapy to 2-drug therapy. Now there is a recent literature suggesting a single-drug
      therapy may be safe and adequate. In fact, using zosyn (piperacillin-tazobactam) as a
      single-drug therapy, there are additional benefits of simplicity, compliance, and lower
      infectious complications. Currently surgeons are already using both 2-drug regimen
      (ceftriaxone/metronidazole) and single-drug regimen (zosyn) interchangeable as both are FDA
      approved antibiotics for intra-abdominal infection. There is a clear need to compare outcomes
      between these two options.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The diagnosis of perforated appendicitis will be documented intraoperatively with photos of
      extraluminal fecal contents or visible holes on the appendix. Patients will be randomized to
      121 in each arm. Postoperative antibiotic therapy option will be decided based on blinded
      sequence model. 30 day postoperative follow up visit or calls will be made to assess and
      collect infectious complications.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 22, 2017</start_date>
  <completion_date type="Anticipated">May 22, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 22, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Intra-abdominal Abscess</measure>
    <time_frame>30 days</time_frame>
    <description>Intra-abdominal abscess documented by ultrasound or computerized tomography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative Surgical Site Infection</measure>
    <time_frame>30 days</time_frame>
    <description>surgical site infections including superficial port site infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Readmission</measure>
    <time_frame>30 days</time_frame>
    <description>readmission within 30 days for any gastrointestinal complaints or infectious complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Antibiotic Charge</measure>
    <time_frame>30 days</time_frame>
    <description>any additional antibiotics prescribed due to infectious complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interventions for postoperative abscess</measure>
    <time_frame>30 days</time_frame>
    <description>drain placement by interventional radiology or PICC placement for long term antibiotics</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">242</enrollment>
  <condition>Perforated Appendicitis</condition>
  <condition>Postoperative Infection</condition>
  <arm_group>
    <arm_group_label>2-drug Therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>ceftriaxone/metronidazole</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1-drug Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>piperacillin-tazobactam</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>piperacillin-tazobactam</intervention_name>
    <description>Single drug therapy</description>
    <arm_group_label>1-drug Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Postoperative Perforated Appendicitis (documented by intraoperative photo)

          -  Postoperative Laparoscopic Appendectomy

        Exclusion Criteria:

          -  Nonperforated Gangrenous Appendicitis

          -  Nonperforated Purulent Appendicitis

          -  Open Appendectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justin Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Phoenix Childrens Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Justin Lee, MD</last_name>
    <phone>(602) 933-7007</phone>
    <email>jlee8@phoenixchildrens.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Phoenix Children's Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Justin Lee, MD</last_name>
      <phone>602-933-7007</phone>
      <email>jlee8@phoenixchildrens.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 18, 2017</study_first_submitted>
  <study_first_submitted_qc>September 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2017</study_first_posted>
  <last_update_submitted>September 18, 2017</last_update_submitted>
  <last_update_submitted_qc>September 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Tazobactam</mesh_term>
    <mesh_term>Piperacillin</mesh_term>
    <mesh_term>Piperacillin, tazobactam drug combination</mesh_term>
    <mesh_term>Penicillanic Acid</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

